169 related articles for article (PubMed ID: 17134675)
1. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
3. Probing the roles of non-homologous insertions in the N-terminal domain of Plasmodium falciparum hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase.
Rattanachuen W; Jönsson M; Swedberg G; Sirawaraporn W
Mol Biochem Parasitol; 2009 Dec; 168(2):135-42. PubMed ID: 19631695
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
6. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
Vinnicombe HG; Derrick JP
Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
[TBL] [Abstract][Full Text] [Related]
7. The three-dimensional structure of the bifunctional 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase/dihydropteroate synthase of Saccharomyces cerevisiae.
Lawrence MC; Iliades P; Fernley RT; Berglez J; Pilling PA; Macreadie IG
J Mol Biol; 2005 May; 348(3):655-70. PubMed ID: 15826662
[TBL] [Abstract][Full Text] [Related]
8. Folate synthesis in higher-plant mitochondria: coupling between the dihydropterin pyrophosphokinase and the dihydropteroate synthase activities.
Mouillon JM; Ravanel S; Douce R; Rébeillé F
Biochem J; 2002 Apr; 363(Pt 2):313-9. PubMed ID: 11931659
[TBL] [Abstract][Full Text] [Related]
9. Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.
Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):379-87. PubMed ID: 23627736
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
Rao GS; Kumar M
Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
[TBL] [Abstract][Full Text] [Related]
11. Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast.
Patel O; Karnik K; Macreadie IG
FEMS Microbiol Lett; 2004 Jul; 236(2):301-5. PubMed ID: 15251211
[TBL] [Abstract][Full Text] [Related]
12. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
[TBL] [Abstract][Full Text] [Related]
13. Inhibition studies of sulfonamide-containing folate analogs in yeast.
Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design.
Babaoglu K; Qi J; Lee RE; White SW
Structure; 2004 Sep; 12(9):1705-17. PubMed ID: 15341734
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan.
Takahashi T; Kanda T; Iwamoto A
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):159-76. PubMed ID: 15080506
[TBL] [Abstract][Full Text] [Related]
16. Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp.
Thielking DM; Destefano MS; Cynamon MH; Yeo AE
Antimicrob Agents Chemother; 2003 Mar; 47(3):1174. PubMed ID: 12604567
[No Abstract] [Full Text] [Related]
17. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
[TBL] [Abstract][Full Text] [Related]
19. Dihydropteroate synthase from Streptococcus pneumoniae: structure, ligand recognition and mechanism of sulfonamide resistance.
Levy C; Minnis D; Derrick JP
Biochem J; 2008 Jun; 412(2):379-88. PubMed ID: 18321242
[TBL] [Abstract][Full Text] [Related]
20. Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
Otzen T; Wempe EG; Kunz B; Bartels R; Lehwark-Yvetot G; Hänsel W; Schaper KJ; Seydel JK
J Med Chem; 2004 Jan; 47(1):240-53. PubMed ID: 14695838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
